AdventHealth Medical Group Oncology Research at Celebration
Celebration, Florida, United States
Oncologist in Celebration, Florida
400 Celebration Pl # A270, Celebration, FL 34747
About AdventHealth Medical Group Oncology Research at Celebration
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at AdventHealth Medical Group Oncology Research at Celebration
During the past decade, AdventHealth Medical Group Oncology Research at Celebration conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of the Efficacy and Safety of Ocrelizumab in Patients With Relapsing-Remitting Multiple Sclerosis
2008-07-17
2023-12-16
Active, not recruiting
220
A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
2011-03-02
2022-12-31
Completed
735
A Study of Atezolizumab in Combination With Carboplatin or Cisplatin + Pemetrexed Compared With Carboplatin or Cisplatin + Pemetrexed in Participants Who Are Chemotherapy-Naive and Have Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower 132)
2016-04-30
2022-12-13
Completed
578
A Study Evaluating the Efficacy and Safety of Crenezumab Versus Placebo in Participants With Prodromal to Mild Alzheimer's Disease (AD).
2016-03-22
2019-05-31
Terminated
813
A Study of Tiragolumab in Combination With Atezolizumab in Chemotherapy-Naïve Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
2018-08-10
2024-03-31
Active, not recruiting
135
Non-interventional Study of Ocrelizumab in Participants With Relapsing or Primary Progressive Multiple Sclerosis
2018-11-12
2025-07-26
Active, not recruiting
1,700
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of a Higher Dose of Ocrelizumab in Adults With Relapsing Multiple Sclerosis (RMS)
2020-11-26
2029-03-30
Recruiting
865
A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Participants With Primary Progressive Multiple Sclerosis
2020-10-26
2026-12-18
Recruiting
946
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at AdventHealth Medical Group Oncology Research at Celebration
According to Clinical.Site data, the most researched conditions in "AdventHealth Medical Group Oncology Research at Celebration" are
"Advanced Solid Tumors" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials) and "Metastatic Solid Tumors" (1 trials). Many other conditions were trialed in "AdventHealth Medical Group Oncology Research at Celebration" in a lesser frequency.
Clinical Trials Intervention Types at AdventHealth Medical Group Oncology Research at Celebration
Most popular intervention types in "AdventHealth Medical Group Oncology Research at Celebration" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Axitinib" (1 trials), "Binimetinib" (1 trials), "Encorafenib" (1 trials), "PF-06939999 dose escalation" (1 trials) and "PF-06939999 in combination with docetaxel" (1 trials). Other intervention names were less common.
Clinical Trials Genders at AdventHealth Medical Group Oncology Research at Celebration
The vast majority of trials in "AdventHealth Medical Group Oncology Research at Celebration" are
2 trials for "All" genders.
Clinical Trials Status at AdventHealth Medical Group Oncology Research at Celebration
Currently, there are NaN active trials in "AdventHealth Medical Group Oncology Research at Celebration".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in AdventHealth Medical Group Oncology Research at Celebration,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in AdventHealth Medical Group Oncology Research at Celebration, 1 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".